Pular para o conteúdo principal
Ranking Invest

FHTX - Foghorn Therapeutics Inc.

Segmento: HealthcareFoghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-286, a small molecule inhibitor of the enzymatic activity of BRG1 and BRM for the treatment of metastatic uveal melanoma and relapsed and/or refractory acute myeloid leukemia and myelodysplastic syndrome; and FHD-609, a small molecule protein degrader for BRD9 to treat patients with synovial sarcoma. The company is also developing an enzymatic inhibitor and a protein degrader as selective modulators of BRM; and ARID1B selective modulators for the treatment of ovarian, endometrial, colorectal, bladder, and gastric cancers. It has a research collaboration and license agreement with Merck Sharp & Dohme Corp. to discover and develop novel oncology therapeutics against a transcription factor target; and with Loxo Oncology to create novel oncology medicines. Foghorn Therapeutics Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.

Análise Ranking Invest

Valor de Mercado
$ 124.12 Mi
IVR
-3.11Índice proprietário de comparação relativa: -3,11.
IVR2
-2.51Leitura proprietária complementar: -251%.
MLL
-2.51Leitura proprietária complementar: -251%.
Último Balanço Atualizado: 2T2026

O Ranking Invest utiliza metodologia proprietária baseada em dados financeiros públicos; fórmulas e valores intermediários são confidenciais.

Dados da Empresa

Patrimônio Líquido

-$ 81.04 Mi

Dívida Líquida

-$ 68.08 Mi

L4T

-$ 64.58 Mi

MM4T

-270.44%

Indicadores Básicos

ROE

79.69%

Índices de Previsibilidade

Receita Líquida

F0.34

Lucro

B0.16

Margem

C0.42

Índices de Tendência

Receita Líquida

D2.52

Lucro

A8.50

Margem

B5.01

Índices de Endividamento

DIV/PAT

0.84

DIV/L4T

1.05

Dívidas
Cotação
Gráfico Lucro/Receita Líquida X TrimestrePor padrão são exibidos os últimos 16 trimestres; quando houver mais trimestres disponíveis, use o botão junto à tabela de resultados para expandir o histórico.